Delivery vehicle
Heavy Chain
H
Associated with receptor recognition, membrane translocation and intracellular delivery in the conventional architecture.
RAW MATERIALS · LIGHT-CHAIN SKIN SCIENCE
BEYOND
THE HEAVY CHAIN.
A new route for skin-focused science.
O-LABORATORY explores a recombinant Light-Chain platform built around a simple scientific idea: keep the active principle, then redesign the delivery route for a different mission.
The Heavy Chain delivers. The Light Chain acts.
RECOMBINANT PLATFORMSEOUL · KOREA
LIGHT-CHAIN CORE
MISSION 01
O-BLOXIN® · TOPICAL
MISSION 02
O-BOTLIX® · DERMAL
01 · THE CLASSIC ARCHITECTURE
One neurotoxin. Two functional chains.
The conventional architecture separates two jobs: a Heavy Chain associated with recognition and delivery, and a Light Chain that carries the catalytic function.
Catalytic function
Light Chain
L
The catalytic component — the active scientific principle at the center of the platform story.
The architecture worked for its original mission. The question was whether the route could be redesigned for another one.
02 · THE SCIENTIFIC PIVOT
Keep the active principle. Redesign the route.
As the scientific focus moved closer to the skin, O-LABORATORY reframed the delivery problem: separate the catalytic function from the conventional delivery architecture and engineer a purpose-built route around it.
The clinical need moved closer to the skin.
CONVENTIONAL ARCHITECTURE
Heavy Chain · Delivery Vehicle
Light Chain · Catalytic Function
ENGINEERED RECOMBINANT PLATFORM
Light-Chain Catalytic Domain
Engineered Delivery Sequence
One question changed the direction: can delivery be redesigned for a different mission?
03 · RECOMBINANT PROTEIN ENGINEERING
From genetic construct to selected lead.
The platform is developed through a structured recombinant-protein workflow that combines the Light-Chain domain with an engineered delivery sequence as one fusion-protein concept.
01
Design
02
Clone
03
Express
04
Purify
05
Screen
06
Select
SHARED SCIENTIFIC CORE
One scientific core. Two engineered delivery missions.
O-BLOXIN®
O-BOTLIX®
04 · TWO ENGINEERED MISSIONS
One platform. Different delivery routes.
Two lead directions emerged from the same scientific backbone. Each is presented according to its intended access level and regulatory readiness.
PUBLIC-SAFE PROFILE
O-BLOXIN®
Topical by Design
O
A topical-oriented recombinant platform direction designed around skin-focused delivery and formulation development.
Topical-oriented development mission
Recombinant protein platform
Designed for formulation evaluation
HCP / B2B CONTROLLED ACCESS
O-BOTLIX®
Dermal by Design
O
A dermal-oriented development direction. Detailed mechanism, professional-use positioning and technical claims remain controlled until scientific and regulatory approval for the relevant market.
Dermal-oriented development mission
Professional technical evaluation pathway
Controlled scientific access
05 · SCIENCE ACCESS
The right information, at the right access level.
Public scientific storytelling remains separate from professional technical content and NDA-protected evaluation material.
01PUBLIC
Discover the Science
Light-Chain story, simplified architecture, recombinant platform and approved public visuals.
02HCP / B2B
Explore Professional Science
Qualified professional access for approved mechanism, applications and technical evaluation material.
03NDA
Protected Evaluation
Confidential composition, unpublished studies, process information and evaluation files after NDA activation.
RAW MATERIAL EVALUATION
Interested in the Light-Chain platform?
Tell us about your company, target market and development objective. The appropriate scientific, technical or NDA pathway can then be opened according to the request.